Physician profile
Sharon Harris
NPI 1801170162
$2,572.75
in general payments reported to CMS, 2019-2025
11 companies · $694 in 2025
The $694 reported for 2025 was more than what 93% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $145 · 2021: $424 · 2022: $317 · 2023: $222 · 2024: $534 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,171.52 | 2022-2025 | |
| Align Technology, INC. | $478.99 | 2019-2022 | |
| Straumann USA LLC | $201.03 | 2022-2025 | |
| Solventum Corporation | $148.33 | 2025 | 3m Filtek, 3m Clinpro |
| Keystone Dental INC. | $146.67 | 2019 | |
| Zimmer Biomet Holdings, INC. | $131.54 | 2020-2021 | |
| 3m Company | $124.07 | 2022-2023 | Scotchbond Universal Plus |
| Dentsply Sirona INC | $73.84 | 2019-2021 | |
| Voco America INC. | $58.58 | 2019-2025 | Ionostar Plus, Meron Plus Qm, Ionoseal |
| Vertex Pharmaceuticals Incorporated | $26.52 | 2025 | |
| Kulzer, LLC | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.